You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 49 No. 5, May 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Albendazole therapy for giant subarachnoid cysticerci

O. H. Del Brutto, J. Sotelo, R. Aguirre, E. Diaz-Calderon and T. A. Alarcon
Neurologic Service, Regional Hospital of Ecuadorian Institute of Social Security of Guayaquil.

Albendazole is considered to be the drug of choice for treatment of parenchymal brain cysticercosis. Its efficacy, however, for treatment of subarachnoid cysticerci has not been established, to our knowledge. In this study, we treated four patients who had giant subarachnoid cysticerci with albendazole at daily doses of 15 mg/kg of body weight for 8 days. Computed tomographic studies showed that all cysts disappeared 3 months after the end of treatment. This was associated with marked clinical improvement in every case. Our results indicated that albendazole is highly effective for treatment of this form of the disease.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

NEW CONCEPTS IN THE DIAGNOSIS AND MANAGEMENT OF NEUROCYSTICERCOSIS (TAENIA SOLIUM)
GARCIA et al.
Am J Trop Med Hyg 2005;72:3-9.
ABSTRACT | FULL TEXT  

Topical Review: Neurocysticercosis in Children
Singhi and Singhi
J Child Neurol 2004;19:482-492.
ABSTRACT  

Current Consensus Guidelines for Treatment of Neurocysticercosis
Garcia et al.
Clin. Microbiol. Rev. 2002;15:747-756.
ABSTRACT | FULL TEXT  

Medical Treatment for Neurocysticercosis Characterized by Giant Subarachnoid Cysts
Proano et al.
NEJM 2001;345:879-885.
ABSTRACT | FULL TEXT  

Clinical Spectrum of 500 Children With Neurocysticercosis and Response to Albendazole Therapy
Singhi et al.
J Child Neurol 2000;15:207-213.
ABSTRACT  

Caution With Praziquantel in Neurocysticercosis
Fong et al.
Stroke 1997;28 :1648-1649.
FULL TEXT  

Antiparasitic Drugs
Liu and Weller
NEJM 1996;334:1178-1184.
FULL TEXT  

Case 8-1993: Cysticercosis
Del Brutto et al.
NEJM 1993;329:813-813.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.